Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

9 -11 January 2013
Health Economists' Study Group (HESG), Exeter
Helen Dakin 'Independence, interactions and inference in partial factorial trials'

24 January 2013
University of Oxford, Department of Public Health, Research in Progress Seminars
Reem Hafez 'The impact of health insurance on financial risk protection in rural Ningxia'

4 February 2013
MRC Hubs for Trials Methodology Research, Annual Meeting, Oxford
Claire Simons 'Review of methods to study heterogeneity and to extrapolate in clinical trial - driven cost-effectiveness analysis' (work in collaboration with Boby Mihaylova and Iryna Schlackow)

1 March 2013
J.E. Cairnes School of Business & Economics, National University of Ireland, Galway (NUI Galway)
Alastair Gray 'Economic aspects of chronic disease: modelling diabetes and its complications'

12 March 2013
ScHARR (School of Health and Related Research), The University of Sheffield
Helen Dakin 'The influence of cost-effectiveness and other factors on NICE decisions'

21 March 2013
OCTET End of Study Conference, London
J. Simon, P. Anand, A. Gray, J. Rugkasa, K. Yeeles, T. Burns and the OCTET Team 'Operationalising the capabilities approach for outcome measurement in the OCTET study'

3rd April 2013
10º Simposio do NECF do ISCSEM, Instituto Superior de Ciencias da Saude – Egas Moniz, Monte da Caparica, Portugal
Jose Leal 'Health economics and the allocation of healthcare resources'

3rd-5th April 2013
Royal Economic Society Annual Conference, Royal Holloway, University of London
Indranil Dutta, Laurence Roope and Horst Zank 'The Endogenous Poverty Line: Existence and Implications'

11th April 2013
HDCA Heath and Disability Thematic Group, Webinar
J. Simon, P. Anand, A. Gray, J. Rugkasa, K. Yeeles, T. Burns and the OCTET Team. 'Operationalising the capabilities approach for outcome measurement in the OCTET study'

23 April 2013
Office of Health Economics, London
Helen Dakin ‘The influence of cost-effectiveness and other factors on NICE decisions’

25 April 2013
Harvard’s Global Health and Population Department’s 50th Anniversary
Winnie Yip 'WATCH: Strengthening Health Systems for Effective Coverage'

8 May 2013
Oxford Reginal Paediatric Registrar Training Day, John Radcliffe Hospital, Oxford
Mara Violato ‘Child health inequalities in the UK: does money matter?’

May 2013
National Workshop 'Developing a Health Needs Assessment tool to understand and meet the needs of people in contact with Probation Services', London
Anees Abdul Pari 'An exploratory study of health and wellbeing of offenders on probation in England'

10 June 2013
London School of Economics, London
Sarah Wordsworth ‘Translating genomic technologies into the NHS: What can health economics add?’

19 June 2013
Austrian Public Health Society Annual Meeting, St Polten, Austria
Judit Simon 'Towards a new understanding of public health'

26 June 2013
Health Econometrics and Data Group (HEDG), York
Laurence Roope, Paul Anand ‘An Economic Analysis of Child Development and Happiness’

26-28 June 2013
Health Economists' Study Group, University of Warwick
Rachael Morton, Lauren Haydu, Stephen Jan, Bruce Armstrong, John Thompson 'Does socio-economic status predict melanoma thickness, disease-free survival or melanoma-specific survival? A prospective single-centre cohort study in Australia'
Mara Violato, Eduardo Fé, Alastair Gray 'Discontinuity designs in health economics: Efficiency and heterogeneity in estimations of causal effects'
Claire Simons, Oliver Rivero-Arias, Ly-Me Yu and Judit Simon 'Missing data in the health related quality of life EQ-5D-3L instrument: Should we impute individual domains or the actual index?'

3 July 2013
Organisation for Economic Co-operation and Development (OECD) Universities conference, Paris
Laurence Roope, Paul Anand ‘An Economic Analysis of Child Development and Happiness’

7-10 July 2013
iHEA International Health Economics Association, 9th World Congress
Presentations by members of HERC

17-20 July 2013
8th World Congress on Melanoma, Hamburg
Rachael Morton
, Lauren Haydu, Stephen Jan, Bruce Armstrong, John Thompson 'Does socio-economic status predict melanoma thickness, disease-free survival or melanoma-specific survival? A prospective single-centre cohort study in Australia'
Joshua Lee, Rachael Morton,  Lauren Haydu, John Thompson 'Does socio-economic status influence clinical trial participation for patients with melanoma'
Rachael Morton,  Johan Vessey, Robin Saw 'Lymphedema and utility-based quality of life following sentinel node biopsy'
Rachael Morton, Gerald Fogarty, Madeleine King, Angela Hong, Anna Nowak 'Methods for the economic evaluation of whole brain radiotherapy alongside a randomised controlled trial'

9-12 September 2013
Human Development and Capability Association, Managua, Nicaragua
Judit Simon 'How do severe mental illness and community coercion affect people’s capabilities?'

22 November 2013
National University of Ireland, Galway
Ramón Luengo-Fernandez 'Economic Burden of Cancer across the European Union: a population-based cost analysis'

22 November 2013
Translational Research Institute (TRI), Queensland University of Technology, Brisbane,
José Leal 'Estimating the cost-effectiveness of prostate cancer screening in the UK and Ireland: Validation of the synthesis framework'

2 December 2013
Centre for Health Policy, Programs and Economics, The University of Melbourne
José Leal 'Synthesis framework to estimate cost-effectiveness of newborn screening for a rare metabolic condition in the absence of direct evidence'

3 December 2013
Royal Brisbane and Women’s Hospital, Brisbane
José Leal 'Early detection/prevention of neutropenic sepsis in cancer patients: a cost utility evaluation'

10 December 2013
Institute of Health and Biomedical Innovation, Brisbane
José Leal 'Cost-effectiveness of DNA testing for hypertrophic cardiomyopathy'